- Home
- / Jumpcan Pharmaceutical
Jumpcan Pharmaceutical
Stock Price
¥30.6
2024-10-29
Market Capitalization
¥28.1 B
2024-10-29
Revenue
¥6.1 B
FY, 2025
Jumpcan Pharmaceutical Summary
Company Summary
- Overview
- Jumpcan Pharmaceutical (济川药业) is a manufacturer and distributor of chemical-based and medicine health products. It is engaged in the production and sales of drugs in gynecology, pediatrics, gastroenterology, pneumology, geriatrics, etc.
- Type
- Public
- Status
- Active
- Founded
- 1997
- Website
- http://www.jumpcan.com
- Cybersecurity rating
Table of Contents
Jumpcan Pharmaceutical Financials
Summary Financials
- Revenue (Q1, 2026)
- ¥1.2B
- Gross profit (Q1, 2026)
- ¥972.0M
- Net income (Q1, 2026)
- ¥399.1M
- Cash (Q1, 2026)
- ¥3.9B
- EBIT (Q1, 2026)
- ¥407.8M
- Enterprise value
- $25.3B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026